FIELD: medicine; cardiology; cardiovascular and endovascular surgery.
SUBSTANCE: invention can be used to determine further management of patients with coronary heart disease (CHD) after percutaneous coronary intervention (PCI). After coronary angiography (CG) and subsequent PCI on the infarct-associated artery in patients with coronary heart disease, the angiographic success of the intervention on the infarct-associated artery is assessed based on the PCI success criteria and the TIMI scale, and an automated assessment of the extent and nature of lesions of the entire coronary bed is performed using the QCA angiographic unit. Based on the data obtained, one of the classes of angiographic results of PCI is distinguished — radical, conditionally radical and palliative, and further tactics of patient management are determined.
EFFECT: method allows to evaluate the success of the performed PCI and determine the postoperative management of patients with coronary artery disease, depending on the degree and nature of lesions of the entire coronary bed by assessing the totality of the most significant indicators.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PERFORMING ASPIRATION THROMBOEMBOLECTOMY WITH GUIDING CATHETER IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2023 |
|
RU2805970C1 |
METHOD OF DETERMINING A COMPLEX BIFURCATION LESION OF THE CORONARY ARTERIES | 2022 |
|
RU2802855C1 |
METHOD OF ACUTE MYOCARDIAL INFARCTION TREATMENT | 2008 |
|
RU2365380C1 |
METHOD FOR ENDOVASCULAR CORRECTION OF NO-REFLOW PHENOMENON IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION OF CULPRIT ARTERY | 2014 |
|
RU2574123C1 |
METHOD FOR STENT THROMBOSIS PREDICTION IN THE PATIENTS WITH ACUTE CORONARY SYNDROME AFTER A PERCUTANEOUS CORONARY INTERVENTION WITH A BACKGROUND OF DOUBLE ANTIPLATELET THERAPY | 2018 |
|
RU2690892C1 |
METHOD OF HAEMODYNAMIC SUPPORT AND PROTECTION OF MYOCARDIUM IN ENDOVASCULAR CORONARY REVASCULARISATION IN HIGH-RISK PATIENTS | 2012 |
|
RU2479250C1 |
METHOD FOR PREDICTING ADVERSE OUTCOMES UP TO 12 MONTHS IN PATIENTS WITH ACUTE CORONARY SYNDROME | 2020 |
|
RU2747693C1 |
METHOD FOR PREVENTING THE "NO-REFLOW" PHENOMENON DURING CORONARY ARTERY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH ST ELEVATION DUE TO MASSIVE THROMBOSIS | 2021 |
|
RU2786150C1 |
METHOD FOR PREDICTION OF EJECTION FRACTION OF LEFT VENTRICULAR FOR TWO-YEAR PERIOD AFTER CORONARY ARTERY STENTING IN ACUTE CORONARY SYNDROME | 2021 |
|
RU2787174C1 |
METHOD OF SELECTION OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND STAGING OF ST SEGMENT AFTER THROMBOLITIC THERAPY FOR CARRYING OUT OF X-RAY CARDIOVASCULAR CORONARY INTERFERENCE (CCI) | 2015 |
|
RU2624817C2 |
Authors
Dates
2023-09-05—Published
2022-11-30—Filed